Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Cash Flow-to-Debt Ratio
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥227.64 Million could theoretically repay 0% of its total liabilities (CN¥2.29 Billion) in one year. See 002020 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Zhejiang Jingxin Pharmaceutical Co Ltd across 24 annual periods. Also explore net asset growth rate of Zhejiang Jingxin Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Zhejiang Jingxin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market cap of Zhejiang Jingxin Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.35x | CN¥781.35 Million | CN¥2.25 Billion | ▲ +18.3% |
| 2024 | 0.29x | CN¥726.16 Million | CN¥2.48 Billion | ▼ -13.1% |
| 2023 | 0.34x | CN¥824.69 Million | CN¥2.45 Billion | ▼ -13.7% |
| 2022 | 0.39x | CN¥855.78 Million | CN¥2.19 Billion | ▲ +68.9% |
| 2021 | 0.23x | CN¥365.02 Million | CN¥1.58 Billion | ▼ -21.8% |
| 2020 | 0.30x | CN¥513.21 Million | CN¥1.73 Billion | ▲ +5.9% |
| 2019 | 0.28x | CN¥535.30 Million | CN¥1.91 Billion | ▼ -24.2% |
| 2018 | 0.37x | CN¥523.40 Million | CN¥1.42 Billion | ▼ -10.1% |
| 2017 | 0.41x | CN¥385.01 Million | CN¥938.43 Million | ▲ +40.3% |
| 2016 | 0.29x | CN¥252.69 Million | CN¥864.23 Million | ▲ +37.3% |
| 2015 | 0.21x | CN¥144.69 Million | CN¥679.39 Million | ▼ -32.6% |
| 2014 | 0.32x | CN¥210.49 Million | CN¥666.12 Million | ▲ +44.2% |
| 2013 | 0.22x | CN¥111.03 Million | CN¥506.65 Million | ▲ +92.1% |
| 2012 | 0.11x | CN¥60.28 Million | CN¥528.40 Million | ▼ -29.9% |
| 2011 | 0.16x | CN¥69.41 Million | CN¥426.39 Million | ▲ +72.0% |
| 2010 | 0.09x | CN¥59.55 Million | CN¥629.02 Million | ▼ -57.3% |
| 2009 | 0.22x | CN¥135.38 Million | CN¥610.06 Million | ▲ +381.0% |
| 2008 | 0.05x | CN¥29.98 Million | CN¥649.89 Million | ▲ +137.7% |
| 2007 | -0.12x | CN¥-87.60 Million | CN¥716.18 Million | ▼ -3945.1% |
| 2006 | 0.00x | CN¥-1.45 Million | CN¥478.23 Million | ▼ -101.4% |
| 2005 | 0.22x | CN¥61.82 Million | CN¥279.27 Million | ▲ +523.5% |
| 2004 | 0.04x | CN¥6.43 Million | CN¥181.11 Million | ▼ -86.9% |
| 2003 | 0.27x | CN¥46.18 Million | CN¥170.36 Million | ▼ -28.9% |
| 2002 | 0.38x | CN¥45.50 Million | CN¥119.35 Million | — |